pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

5,159 catalysts · 5,159 phase readout · 2,304 8k filing · 315 pdufa · 259 earnings · 2 approval · 1 adcom

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-27: 0 catalysts2026-07-28: 0 catalysts2026-07-29: 0 catalysts2026-07-30: 33 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 13 catalysts2026-08-05: 16 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 1 catalyst2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 1 catalyst2026-10-21: 1 catalyst2026-10-22: 2 catalysts2026-10-23: 0 catalysts2026-10-24: 0 catalysts2026-10-25: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: phase readout×clear all
type
  • phase readout5,159
  • 8k filing2,304
  • pdufa315
  • earnings259
  • approval2
  • adcom1
therapy area

no tagged catalysts yet

Date TBD

50
›NOT_YET_RECRUITINGphase readoutNCT07544199: Transdiagnostic Dimensional Profiling of Neurodevelopmental Disorders

Sponsor: IRCCS Eugenio Medea. Phase: . Conditions: Neurodevelopmental Disorder (Diagnosis)

full page →ctgov ↗
›RECRUITINGphase readoutNCT04334031: Deployment o the Multidisciplinary Prospective Cohort Imminent

Sponsor: University Hospital, Lille. Phase: NA. Conditions: Chronic Inflammatory Disease, Angioedema, Severe Asthma, Lupus, Atopic Dermatitis, Psoriatic Arthritis, Multiple Sclerosis, Systemic Sclerosis, Behçet Disease

full page →ctgov ↗
›RECRUITINGphase readoutNCT02577731: Hematopoietic Stem Cell Dysfunction in the Elderly After Severe Injury

Sponsor: University of Florida. Phase: NA. Conditions: Trauma Injury

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT04903002: Evaluating the Efficacy of Intranasal Oxytocin on Chronic Pain

Sponsor: Memorial University of Newfoundland. Phase: PHASE2. Conditions: Chronic Pain

full page →ctgov ↗
›RECRUITINGphase readoutNCT06915337: Magnet Anastomosis in Patients Undergoing Gastric Surgery

Sponsor: GI Windows, Inc.. Phase: NA. Conditions: Gastric Anastomosis (Site)

full page →ctgov ↗
›COMPLETEDphase readoutNCT03439137: Efficacy and Safety Study to Evaluate MT-6548 in Hemodialysis Subjects Currently Receiving ESAs With Anemia Associated With Chronic Kidney Disease in Japan

Sponsor: Tanabe Pharma Corporation. Phase: PHASE3. Conditions: Anemia; Hemodialysis Dependent Chronic Kidney Disease

full page →ctgov ↗
›RECRUITINGphase readoutNCT05642572: Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

Sponsor: SWOG Cancer Research Network. Phase: PHASE2. Conditions: Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8

full page →ctgov ↗
›TERMINATEDphase readoutNCT06110195: Study of Xevinapant With Radiation and Chemotherapy for Patients With Head and Neck Cancer

Sponsor: University of Chicago. Phase: PHASE1. Conditions: Head and Neck Cancer, Head and Neck Neoplasms, Squamous Cell Carcinoma of Head and Neck

full page →ctgov ↗
›RECRUITINGphase readoutNCT07338539: BIO-SHORT: Biologically Guided Short-Course Hypofractionated RT for Poor-Prognosis GBM

Sponsor: Tata Memorial Centre. Phase: PHASE2. Conditions: Glioma

full page →ctgov ↗
›WITHDRAWNphase readoutNCT06701175: Knee Arthroscopy for Pain Control

Sponsor: University of Alabama at Birmingham. Phase: NA. Conditions: Knee Arthroscopy

full page →ctgov ↗
›COMPLETEDphase readoutNCT06333457: Presence and Relapse Rates in Patients With Alcohol Use Disorder Using Virtual Reality

Sponsor: Charite University, Berlin, Germany. Phase: . Conditions: Alcohol Dependence

full page →ctgov ↗
›RECRUITINGphase readoutNCT03980457: Effects of Exoskeleton-Assisted Gait Training on Functional Rehabilitation Outcomes in Patients With Stroke

Sponsor: University of Oklahoma. Phase: NA. Conditions: Stroke, Weakness of Extremities as Sequela of Stroke

full page →ctgov ↗
›RECRUITINGphase readoutNCT07395401: Evaluation of Zinc Oxide Eugenol and Iodoform-Calcium Hydroxide as Filling Materials in Primary Molar Root Canals Prepared by Rotary and Manual Files

Sponsor: October University for Modern Sciences and Arts. Phase: NA. Conditions: Carious Primary Molars Indicated for Pulpectomy

full page →ctgov ↗
›RECRUITINGphase readoutNCT07465081: Ultra-processed Food Consumption and Behavioral Disorder and Cognitive Function

Sponsor: China Medical University Hospital. Phase: NA. Conditions: ADD/ADHD

full page →ctgov ↗
›RECRUITINGphase readoutNCT07392281: Efficacy and Mechanisms of Macitentan for Non-Coronary Obstructive Angina

Sponsor: China-Japan Friendship Hospital. Phase: EARLY_PHASE1. Conditions: Non-Coronary Obstructive Angina

full page →ctgov ↗
›RECRUITINGphase readoutNCT06395181: Whole Food Plant-based Diet Effect on Obstructive Sleep Apnea

Sponsor: Mayo Clinic. Phase: NA. Conditions: Obstructive Sleep Apnea, Daytime Sleepiness

full page →ctgov ↗
›COMPLETEDphase readoutNCT03190681: Motivation and Methylphenidate

Sponsor: Institut National de la Santé Et de la Recherche Médicale, France. Phase: EARLY_PHASE1. Conditions: Motivation, Apathy, Impulsive Behavior

full page →ctgov ↗
›RECRUITINGphase readoutNCT06589128: Efficacy of Investigator Product for the Amelioration of Digital Eye Strain in Children

Sponsor: Universiti Sains Malaysia. Phase: NA. Conditions: Digital Eye Strain (DES)

full page →ctgov ↗
›RECRUITINGphase readoutNCT06091228: The Additional Effect of Tongue Scraping on Halitosis Parameters in Initial Periodontal Therapy

Sponsor: Universitaire Ziekenhuizen KU Leuven. Phase: NA. Conditions: Periodontitis, Halitosis, Tongue Condition

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05025800: ALX148, Rituximab and Lenalidomide for the Treatment of Indolent and Aggressive B-cell Non-Hodgkin Lymphoma

Sponsor: M.D. Anderson Cancer Center. Phase: PHASE1. Conditions: Aggressive B-Cell Non-Hodgkin Lymphoma, Ann Arbor Stage III Grade 2 Follicular Lymphoma, Ann Arbor Stage III Grade 3 Follicular Lymphoma, Ann Arbor Stage III Marginal Zone Lymphoma, Ann Arbor Stage IV Grade 1 Follicular Lymphoma, Ann Arbor Stage IV Grade 2 Follicular Lymphoma, Ann Arbor Stage IV Grade 3 Follicular Lymphoma, Ann Arbor Stage IV Marginal Zone Lymphoma, Composite Lymphoma, Indolent B-Cell Non-Hodgkin Lymphoma, Refractory Aggressive B-Cell Non-Hodgkin Lymphoma, Refractory Follicular Lymphoma, Refractory Grade 3b Follicular Lymphoma, Refractory High Grade B-Cell Lymphoma, Refractory Mantle Cell Lymphoma, Refractory Marginal Zone Lymphoma, Refractory Primary Mediastinal (Thymic) Large B-Cell Lymphoma, Refractory Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma, Refractory Transformed Marginal Zone Lymphoma to Diffuse Large B-Cell Lymphoma, Richter Syndrome

full page →ctgov ↗
›COMPLETEDphase readoutNCT07480200: Effect of Trigger Point Cryostimulation on Exercise-Induced Tremor in Adolescent Swimmers

Sponsor: Józef Piłsudski University of Physical Education. Phase: NA. Conditions: Physiological Tremor, Exercise-Induced Neuromuscular Fatigue

full page →ctgov ↗
›RECRUITINGphase readoutNCT07455292: Phenotyping Left Ventricle Failure With Hemodynamic Biomarkers From 4D Flow Magnetic Resonance Imaging

Sponsor: IRCCS Policlinico S. Donato. Phase: NA. Conditions: Left Ventricle Function, Transcatheter Aortic Valve Replacement (TAVR), Aortic Valve Stenosis

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT04886492: CorEvitas SPHERES (Synergy of Prospective Health & Experimental Research for Emerging Solutions) Registry for Neuromyelitis Optica Spectrum Disorder (NMOSD)

Sponsor: CorEvitas. Phase: . Conditions: Neuromyelitis Optica Spectrum Disorder

full page →ctgov ↗
›COMPLETEDphase readoutNCT07438236: Cognitive Performance and Mood After Ingestion of Dietary Supplement by University Students

Sponsor: Cooperativa de Ensino Superior, Politécnico e Universitário. Phase: NA. Conditions: Cognitive Performance, Mood, Dietary Supplement, Safety

full page →ctgov ↗
›COMPLETEDphase readoutNCT04535011: PRACT to Investigate Controlling Alcohol Related Harms in a Low-Income Setting; Emergency Department BIs in Tanzania

Sponsor: Duke University. Phase: NA. Conditions: Alcohol Use Disorder, Injury Traumatic, Trauma

full page →ctgov ↗
›RECRUITINGphase readoutNCT05508971: Treatment of Obstructive Sleep Apnea With Personalized Surgery in Children With Down Syndrome (TOPS-DS)

Sponsor: Oregon Health and Science University. Phase: NA. Conditions: Obstructive Sleep Apnea, Down Syndrome

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT05214092: Cortical Contributions to FFR: Post-Op Outcomes

Sponsor: University of Pittsburgh. Phase: NA. Conditions: Language

full page →ctgov ↗
›RECRUITINGphase readoutNCT06991192: ACL Reconstruction Rehabilitation With Exercise and Psychological Support

Sponsor: HealthPartners Institute. Phase: NA. Conditions: Anterior Cruciate Ligament Reconstruction Rehabilitation

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07416734: RCT of HeartBot in Women

Sponsor: University of California, San Francisco. Phase: NA. Conditions: Participants Must be Women Aged 25 Years or Older, Participants Should Have no Self-reported History of Heart Disease or Stroke, Participants Should Have no Terminal Illness or Diagnosed Cognitive Impairment, Including Alzheimer's Disease, Participants Should Not be a Healthcare Professionals or Healthcare Trainees, Participants Should Not be Employed in the Healthcare Field, Participants Should Reside in the United States and be a University of California, San Francisco Health Patient, Participants Should Possess a Smartphone With an Active Data Plan or Access to Wi-Fi

full page →ctgov ↗
›RECRUITINGphase readoutNCT07220564: A Research Study Looking at How Different Doses of Study Medicine (Inno8) Work in the Body of People With Haemophilia A

Sponsor: Novo Nordisk A/S. Phase: PHASE1. Conditions: Haemophilia A

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07412509: Can 3D Modeling Enhance Patient Understanding, Education, and Surgical Outcomes in Gender Affirming Peritoneal Vaginoplasty?

Sponsor: University of Chicago. Phase: . Conditions: Vaginoplasty, Gender Dysphoria, Adult

full page →ctgov ↗
›RECRUITINGphase readoutNCT07191509: Effects of Tracheostomy Decannulation on Respiratory Function

Sponsor: Capital Medical University. Phase: . Conditions: Tracheostomy Decannulation

full page →ctgov ↗
›TERMINATEDphase readoutNCT04179864: A Study of Tazemetostat With Enzalutamide or Abiraterone/Prednisone in Participants With Advanced Prostate Cancer

Sponsor: Epizyme, Inc.. Phase: PHASE1. Conditions: Metastatic Prostate Cancer, Metastatic Castration-resistant Prostate Cancer

full page →ctgov ↗
›COMPLETEDphase readoutNCT06164951: A Study to Evaluate the Efficacy and Safety of Infigratinib in Children and Adolescents With Achondroplasia

Sponsor: QED Therapeutics, a BridgeBio company. Phase: PHASE3. Conditions: Achondroplasia

full page →ctgov ↗
›RECRUITINGphase readoutNCT07520929: Acute Sauna Session and Glucose Control

Sponsor: University of Prince Edward Island. Phase: NA. Conditions: Obesity & Overweight

full page →ctgov ↗
›COMPLETEDphase readoutNCT05906602: Motor and Neurophysiological Changes After Ischemic Conditioning in Individuals With Stroke

Sponsor: University of Illinois at Chicago. Phase: NA. Conditions: Stroke

full page →ctgov ↗
›RECRUITINGphase readoutNCT06385353: DVT Burden and the Risk of Post-thrombotic Syndrome

Sponsor: Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer. Phase: NA. Conditions: Postthrombotic Syndrome

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT06958731: In-plane Versus Real Time Bi-plane Single-operator Laser-assisted With a Innovative T-shaped Probe for Ultrasound-guided Internal Jugular Vein Catheterization:A Randomized Controlled Trial

Sponsor: The First Hospital of Jilin University. Phase: NA. Conditions: Catheterization, Central Venous, Ultrasound Guided

full page →ctgov ↗
›RECRUITINGphase readoutNCT07426731: Comparison of Sacral ESP Block and Dorsal Penile Nerve Block in Pediatric Hypospadias Surgery

Sponsor: Medipol University. Phase: NA. Conditions: Postoperative Pain, Hypospadias

full page →ctgov ↗
›RECRUITINGphase readoutNCT04591002: Osimertinib to Suppress the Progression of GGN(EGFR Mutation-positive)

Sponsor: Samsung Medical Center. Phase: PHASE2. Conditions: Lung Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT06780202: Assessment of Medrol Dosepak to Reduce Opioid Consumption in Foot and Ankle Surgical Patients

Sponsor: Emory University. Phase: PHASE2. Conditions: Foot Injuries and Disorders, Ankle Injuries and Disorders, Achilles Tendon Injury

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07414953: A Phase Ib Study of HS-10504 Combined Therapy in NSCLC

Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd.. Phase: PHASE1. Conditions: Lung Cancer

full page →ctgov ↗
›COMPLETEDphase readoutNCT07318337: Effect of Drospirenone-Ethinyl Estradiol (20microgram vs 30 Microgram) on Free Androgen Index in PCOS

Sponsor: Mst.Sumyara Khatun. Phase: NA. Conditions: PCOS (Polycystic Ovary Syndrome)

full page →ctgov ↗
›RECRUITINGphase readoutNCT06089083: PROmOting Gynecologic Cancer Patients With Frailty to Achieve Functional Recovery

Sponsor: University of California, San Francisco. Phase: . Conditions: Malignant Female Reproductive System Neoplasm, Gynecologic Cancer, Gynecologic Neoplasm

full page →ctgov ↗
›RECRUITINGphase readoutNCT04458883: The Next Leap in Cardiac Magnetic Resonance Imaging:Cycling the Field

Sponsor: University of Aberdeen. Phase: NA. Conditions: Myocardial Infarction

full page →ctgov ↗
›RECRUITINGphase readoutNCT07321041: Effect of Delivery Time on Umbilical Cord Blood Gas Parameters in Cesarean Sections Under General and Spinal Anesthesia

Sponsor: Sisli Hamidiye Etfal Training and Research Hospital. Phase: . Conditions: Umbilical Cord Blood, Cesarean Section Surgery, General Anesthesia, Spinal Anesthesia, Blood Gas Analysis

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05208905: LIFE-BTK PK Sub-study

Sponsor: Abbott Medical Devices. Phase: NA. Conditions: Critical Limb Ischemia (CLI)

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05593094: A Phase 1 Trial of ZN-A-1041 Enteric Capsules or Combination in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Advanced Solid Tumors

Sponsor: Hoffmann-La Roche. Phase: PHASE1. Conditions: Advanced Solid Tumors, HER2-positive Breast Cancer

full page →ctgov ↗
›COMPLETEDphase readoutNCT06195566: Development of PI-ML Algorithm for Prediction of the Real-time Risk for Developing Pre-diabetes

Sponsor: Jelizaveta Sokolovska. Phase: . Conditions: Prediabetic State, Body Weight, Overweight or Obesity, Life Style, Healthy

full page →ctgov ↗
›TERMINATEDphase readoutNCT04258566: Electromagnetic Tracking and Optical Imaging With ICG for Hepatic Biopsies

Sponsor: National Institutes of Health Clinical Center (CC). Phase: NA. Conditions: Hepatocellular Carcinoma

full page →ctgov ↗
← prev
page 20 of 104
next →